Literature DB >> 22956714

The prevalence of ADHD: its diagnosis and treatment in four school districts across two states.

Mark L Wolraich1, Robert E McKeown2, Susanna N Visser3, David Bard4, Steven Cuffe5, Barbara Neas4, Lorie L Geryk2, Melissa Doffing6, Matteo Bottai2, Ann J Abramowitz7, Laoma Beck4, Joseph R Holbrook2, Melissa Danielson3.   

Abstract

OBJECTIVE: To describe the epidemiology of ADHD in communities using a DSM-IVTR case definition.
METHOD: This community-based study used multiple informants to develop and apply a DSM -IVTR-based case definition of ADHD to screening and diagnostic interview data collected for children 5-13 years of age. Teachers screened 10,427 children (66.4%) in four school districts across two states (SC and OK). ADHD ratings by teachers and parent reports of diagnosis and medication treatment were used to stratify children into high and low risk for ADHD. Parents (n = 855) of high risk and gender frequency-matched low risk children completed structured diagnostic interviews. The case definition was applied to generate community prevalence estimates, weighted to reflect the complex sampling design.
RESULTS: ADHD prevalence was 8.7% in SC and 10.6% in OK. The prevalence of ADHD medication use was 10.1% (SC) and 7.4% (OK). Of those medicated, 39.5% (SC) and 28.3% (OK) met the case definition. Comparison children taking medication had higher mean symptom counts than other comparison children.
CONCLUSIONS: Our ADHD estimates are at the upper end of those from previous studies. The identification of a large proportion of comparison children taking ADHD medication suggests that our estimates may be conservative; these children were not included as cases in the case definition, although some might be effectively treated.
© 2012 SAGE Publications.

Entities:  

Keywords:  ADHD; community-based sample; epidemiology; prevalence rate; school sample

Mesh:

Year:  2012        PMID: 22956714     DOI: 10.1177/1087054712453169

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  24 in total

1.  Attention-Deficit/Hyperactivity Disorder (ADHD): Interaction between socioeconomic status and parental history of ADHD determines prevalence.

Authors:  Andrew S Rowland; Betty J Skipper; David L Rabiner; Fares Qeadan; Richard A Campbell; A Jack Naftel; David M Umbach
Journal:  J Child Psychol Psychiatry       Date:  2017-08-12       Impact factor: 8.982

2.  Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.

Authors:  Gregory R Sayer; James J McGough; Jennifer Levitt; Jennifer Cowen; Alexandra Sturm; Edward Castelo; James T McCracken
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-08-02       Impact factor: 2.576

3.  The Prevalence of ADHD in a Population-Based Sample.

Authors:  Andrew S Rowland; Betty J Skipper; David M Umbach; David L Rabiner; Richard A Campbell; Albert J Naftel; Dale P Sandler
Journal:  J Atten Disord       Date:  2013-12-11       Impact factor: 3.256

4.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors:  Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

5.  The impact of case definition on attention-deficit/hyperactivity disorder prevalence estimates in community-based samples of school-aged children.

Authors:  Robert E McKeown; Joseph R Holbrook; Melissa L Danielson; Steven P Cuffe; Mark L Wolraich; Susanna N Visser
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-11-11       Impact factor: 8.829

6.  ADHD and Vision Problems in the National Survey of Children's Health.

Authors:  Dawn K DeCarlo; Mark Swanson; Gerald McGwin; Kristina Visscher; Cynthia Owsley
Journal:  Optom Vis Sci       Date:  2016-05       Impact factor: 1.973

7.  Treated Prevalence of Attention-Deficit/Hyperactivity Disorder Increased from 2009 to 2015 Among School-Aged Children and Adolescents in the United States.

Authors:  Kwame A Nyarko; Scott D Grosse; Melissa L Danielson; Joseph R Holbrook; Susanna N Visser; Stuart K Shapira
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-03-22       Impact factor: 2.576

8.  ADHD and Psychiatric Comorbidity: Functional Outcomes in a School-Based Sample of Children.

Authors:  Steven P Cuffe; Susanna N Visser; Joseph R Holbrook; Melissa L Danielson; Lorie L Geryk; Mark L Wolraich; Robert E McKeown
Journal:  J Atten Disord       Date:  2015-11-25       Impact factor: 3.256

9.  Persistence of Parent-Reported ADHD Symptoms From Childhood Through Adolescence in a Community Sample.

Authors:  Joseph R Holbrook; Steven P Cuffe; Bo Cai; Susanna N Visser; Melinda S Forthofer; Matteo Bottai; Andrew Ortaglia; Robert E McKeown
Journal:  J Atten Disord       Date:  2014-07-03       Impact factor: 3.256

10.  Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.

Authors:  James T McCracken; James J McGough; Sandra K Loo; Jennifer Levitt; Melissa Del'Homme; Jennifer Cowen; Alexandra Sturm; Fiona Whelan; Gerhard Hellemann; Catherine Sugar; Robert M Bilder
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-06-03       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.